DailyDoctor Archive Specialties Get app
Back to the 2 November 2026 edition

Research · 02 of 04

A family telehealth programme improved sun protection but not sunburn in high-risk children

Raise sun protection for the children of every melanoma patient, and expect to revisit it; a single programme did not sustain lower sunburn.

Design
Parallel-group randomised trial with active education control
Population
364 melanoma survivor and child pairs, children aged 8 to 17 with recent sunburn
Primary outcome
Change in child sunburn across two follow-up assessments
Effect
No significant difference over time; sun-protective behaviour B 0.26 (95% CI 0.14 to 0.38)

The FLARE trial randomised 364 pairs of melanoma survivors and their children aged 8 to 17, all of whom had at least one sunburn in the past year. Both arms received four weeks of telehealth education; FLARE added familial melanoma risk education and practical sun-protection skills, while the control covered general skin cancer information.

Over the whole follow-up, the change in sunburn did not differ between groups, so the trial missed its primary endpoint. Children in the FLARE group reported fewer sunburns at the first assessment after the programme and showed larger gains in sun-protective behaviour through the second assessment (B 0.26, 95% CI 0.14 to 0.38).

Children of melanoma survivors carry about twice the lifetime melanoma risk. This trial suggests that education changes habits but that the effect on sunburn fades, so one-off counselling is unlikely to be enough.

  • When treating a melanoma patient, ask whether they have children and whether those children burn.
  • Give families specific behaviours, not just general risk information.
  • Repeat sun-protection advice each season; one session did not hold.
  • Children of melanoma survivors have about twice the lifetime melanoma risk.

Why it matters

Melanoma follow-up is also a chance to protect the next generation.

Don't overread it

The trial missed its primary endpoint; the early sunburn reduction is a secondary finding.

The statistics, in plain English

The primary endpoint, change in sunburn over time, was not significant. The early drop in sunburn and the behaviour gains are secondary findings and should be read as supportive, not proof of benefit.

Read the rest in the app

You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.

QR code to install Daily Doctor
Get Daily Doctor — free

Scan to keep reading on your phone. No account needed to start.

skincancer

Tomorrow morning, before your first patient

One edition a day for dermatology, written by the desk, every claim tied to its paper. Six minutes.

Get the app — free
Daily Doctor All 27 specialties, every morning. Free.
Get the app